Kenneth J Kelley - Net Worth and Insider Trading
Kenneth J Kelley Net Worth
The estimated net worth of Kenneth J Kelley is at least $11 Million dollars as of 2024-11-13. Kenneth J Kelley is the Director of Halozyme Therapeutics Inc and owns about 179,833 shares of Halozyme Therapeutics Inc (HALO) stock worth over $11 Million. Details can be seen in Kenneth J Kelley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth J Kelley has not made any transactions after 2021-04-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth J Kelley
Kenneth J Kelley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth J Kelley owns 1 companies in total, including Halozyme Therapeutics Inc (HALO) .
Click here to see the complete history of Kenneth J Kelley’s form 4 insider trades.
Insider Ownership Summary of Kenneth J Kelley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2021-04-14 | director |
Kenneth J Kelley Latest Holdings Summary
Kenneth J Kelley currently owns a total of 1 stock. Kenneth J Kelley owns 179,833 shares of Halozyme Therapeutics Inc (HALO) as of April 14, 2021, with a value of $11 Million.
Latest Holdings of Kenneth J Kelley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2021-04-14 | 179,833 | 59.64 | 10,725,240 |
Holding Weightings of Kenneth J Kelley
Kenneth J Kelley Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth J Kelley has made a total of 8 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 1 buys and 7 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 5,000 shares on April 14, 2021, which brought Kenneth J Kelley around $225,000.
Insider Trading History of Kenneth J Kelley
- 1
Kenneth J Kelley Trading Performance
GuruFocus tracks the stock performance after each of Kenneth J Kelley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth J Kelley is 12.75%. GuruFocus also compares Kenneth J Kelley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth J Kelley within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kenneth J Kelley's insider trading performs compared to the benchmark.
Performance of Kenneth J Kelley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 28.63 | | | | | |
| Relative Return to S&P 500(%) | 21.56 | | | | | |
Kenneth J Kelley Ownership Network
Ownership Network List of Kenneth J Kelley
Ownership Network Relation of Kenneth J Kelley
Kenneth J Kelley Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
Kenneth J Kelley is the director of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, Kenneth J Kelley made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 280,000 shares made by Michael J. Labarre , a net sale of 200,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .
In summary, during the past 3 months, insiders sold 199,881 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 199,881 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
Kenneth J Kelley Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth J Kelley. You might contact Kenneth J Kelley via mailing address: 1331 Hillview Drive, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
